NCT06341764 Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma Status RECRUITING Phase PHASE2
NCT06340646 Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) Status RECRUITING Phase NA
NCT06302621 Pemigatinib + Afatinib in Advanced Refractory Solid Tumors Status RECRUITING Phase PHASE1
NCT06290856 Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy Status TERMINATED Phase N/A
NCT06258824 MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers Status COMPLETED Phase N/A
NCT06199895 Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer Status RECRUITING Phase PHASE2
NCT06175845 Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma Status NOT_YET_RECRUITING Phase NA
NCT06126406 Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06048289 Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy Status UNKNOWN Phase N/A
NCT06048133 Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) Status RECRUITING Phase PHASE2
NCT06037980 CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence Status RECRUITING Phase PHASE2/PHASE3
NCT06010862 Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT05993429 Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma Status COMPLETED Phase N/A
NCT05967182 A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT05957250 [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer Status RECRUITING Phase NA
NCT05948475 Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma Status RECRUITING Phase PHASE3
NCT05876754 An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma Status RECRUITING Phase PHASE3